Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Synopsis

ICD Research's 'Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries.

Summary

ICD Research's 'Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' is a crucial resource for industry executives and anyone looking to access key information about Astellas Pharma Inc..

ICD Research's 'Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about 'Astellas Pharma Inc.' for business intelligence requirements.
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• Provides data on company financial performance and competitive benchmarking.
• The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.

Reasons To Buy

• Quickly enhance your understanding of 'Astellas Pharma Inc.'.
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.

Key Highlights

Astellas Pharma Inc. (Astellas) is a global pharmaceutical company focused on developing, manufacturing and marketing of pharmaceuticals and related products. The company has superior research and development capabilities to develop new drugs, manufacturing facilities for the manufacturing of products in a cost effective way and efficient in-house sales force to market those products. The company is primarily active in the field of urology, transplantation and oncology. Key brands marketed by the company include Prograf, Vesicare, Protopic, Harnal and Funguard. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, and Philippines among others. Astellas is headquartered at Chuo-Ku in Tokyo, Japan.

Contents

1 BUSINESS ANALYSIS

1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services

2 ANALYSIS OF KEY PERFORMANCE INDICATORS

2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
  2.2.1 Revenue and Operating Profit
  2.2.2 Asset, Liabilities and Capex
  2.2.3 Operational Efficiency
  2.2.4 Valuation
2.3 Competitive benchmarking
  2.3.1 Market Capitalization
  2.3.2 Efficiency
  2.3.3 Capital Expenditure
  2.3.4 Turnover – Inventory and Asset

3 MERGERS & ACQUISITIONS AND PARTNERSHIPS

3.1 M&A and Partnerships Strategy

4 SWOT ANALYSIS

4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats

5 COMPANY STATEMENT

6 HISTORY

7 KEY EMPLOYEES

8 KEY EMPLOYEE BIOGRAPHIES

9 LOCATIONS AND SUBSIDIARIES

9.1 Head Office
9.2 Other locations and Subsidiaries

10 APPENDIX

10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer


LIST OF TABLES

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employees
Table 7: Key Employee Biographies
Table 8: Subsidiaries
Table 9: Locations

LIST OF FIGURES

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Operational Efficiency
Figure 4: Valuation
Figure 5: Market Capitalization
Figure 6: Efficiency
Figure 7: Capital Expenditure
Figure 8: Turnover – Inventory and Asset

COMPANIES MENTIONED

Astellas Pharma Inc. Skip to top